LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
112 hedge funds and large institutions have $178M invested in Lumos Pharma, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
-27
Holders Change %
-19.42%
% of All Funds
2.99%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
42
Reduced
33
Closed
38
Calls
$24.9M
Puts
$8.06M
Net Calls
+$16.9M
Net Calls Change
+$21.9M
Top Buyers
| 1 |
O
OrbiMed
New York
|
$17.8M |
| 2 |
First Eagle Investment Management
New York
|
$24.6M |
| 3 |
QI
QS Investors
New York
|
$2.04M |
| 4 |
HT
HAP Trading
New York
|
$2.56M |
| 5 |
Millennium Management
New York
|
$4.71M |
